At a glance
T2S supplies healthcare professionals with diagnostic and treatment technologies: imaging, equipment and medical solutions. The group has been active in Morocco and sub-Saharan Africa for about 35 years.
History
T2S was founded in 1992 as Technique Science Santé, a distributor of medical technology in Morocco, before expanding into French-speaking sub-Saharan Africa. The holding company has four subsidiaries: T2S and IM Alliance (medical equipment and diagnostics), Cyclopharma (radiopharmacy) and Binarios (digital hospital systems).
Latest published results
Its listing on the Casablanca Stock Exchange in July 2026 was the first of the year. The offer, at MAD 223 per share, was 43.75 times oversubscribed by more than 110,000 investors. It combined a capital increase of about MAD 350 million with the sale of existing shares worth about MAD 750 million.
What to watch
Its first annual results as a listed company, for 2026.
Key dates
- 1992
Founded as Technique Science Santé.
- 2026
AMMC approval on 6 July, offer 43.75 times oversubscribed, first listing on 27 July at MAD 223 per share.
Sources: Hespress, IPO de T2S : l'opération sursouscrite 43,75 fois par 111 149 investisseurs, July 2026; African Markets, fiche société T2S Group Holding, October 29, 2026.
Profile updated on October 29, 2026.